Zhang X and Hu C |
Selecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model. |
2017 |
J Pharm Biomed Anal |
pmid:28024686
|
Addo KK et al. |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. |
2017 |
BMC Infect. Dis. |
pmid:29197331
|
Liu W et al. |
Rapid detection of mutations in erm(41) and rrl associated with clarithromycin resistance in Mycobacterium abscessus complex by denaturing gradient gel electrophoresis. |
2017 |
J. Microbiol. Methods |
pmid:29079298
|
Chang CH et al. |
Non-Tuberculous Mycobacteria Infection Following Autologous Fat Grafting on the Face. |
2017 |
Aesthet Surg J |
pmid:29045552
|
Ikeue T et al. |
Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement. |
2017 |
Intern. Med. |
pmid:28924121
|
Larsen EL et al. |
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials. |
2017 |
Br J Clin Pharmacol |
pmid:28185274
|
Ono S et al. |
Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin. |
2017 |
Helicobacter |
pmid:28098408
|
Gouin-Thibault I et al. |
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. |
2017 |
J. Thromb. Haemost. |
pmid:27893182
|
Park J et al. |
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Clin. Infect. Dis. |
pmid:28011609
|
Park SM et al. |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection. |
2017 |
J. Gastroenterol. Hepatol. |
pmid:27505301
|
Ishiguro N et al. |
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. |
2017 |
PLoS ONE |
pmid:28288170
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Chang CT et al. |
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin. |
2017 |
J. Fish Dis. |
pmid:28422304
|
Furuya H et al. |
SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. |
2017 |
Rheumatology (Oxford) |
pmid:28371927
|
Ye JF et al. |
Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication. |
2017 |
J Dig Dis |
pmid:29119724
|
Sotto RB et al. |
Sub-lethal pharmaceutical hazard tracking in adult zebrafish using untargeted LC-MS environmental metabolomics. |
2017 |
J. Hazard. Mater. |
pmid:28623724
|
Liatsos C and Leontiadis GII |
The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance? |
2017 |
J Gastrointestin Liver Dis |
pmid:28617893
|
Chew CA et al. |
The diagnosis and management of H. pylori infection in Singapore. |
2017 |
Singapore Med J |
pmid:28536725
|
Oikawa R et al. |
Enrichment of Helicobacter pylori mutant strains after eradication therapy analyzed by gastric wash-based quantitative pyrosequencing. |
2017 |
Tumour Biol. |
pmid:28990461
|
Anwar HF et al. |
Synthesis of clarithromycin ketolides chemically modified at the unreactive C10-methyl group. |
2017 |
Bioorg. Med. Chem. |
pmid:28302508
|